Trading Update

Advanced Medical Solutions Grp PLC
06 June 2007


For Immediate Release                                                6 June 2007



                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')
                                 Trading Update


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, today announces an update on current trading prior
to its Annual General Meeting to be held at 11:00am today.

Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated:

'I am pleased to advise that the strong start to the year reported in the
Preliminary Results announced on 13 March 2007 has continued.  The Company is on
track to deliver maiden first half profits and continues to trade well in line
with market expectations for the full year 2007.

'The outlook remains extremely positive. The organic business continues to
perform well with our ActivHeal(R) woundcare range gaining wider acceptance in
the NHS, our presence in the dynamic silver alginate market broadening and
Kimberly-Clark launching InteguSeal* Microbial Sealant in the US. The Group's
financial position continues to improve allowing management to review potential
acquisitions to leverage its technology and distribution base'.



                                   -- ENDS --



For further information, please contact:

Advanced Medical Solutions Group plc                        [phone]
Don Evans (Chief Executive Officer)
Mary Tavener (Group Finance Director)
www.admedsol.com

Buchanan Communications                                    [phone]
Mark Court/Mary-Jane Johnson


* Trademark of Kimberly-Clark Worldwide, Inc. (c) 2007 KCWW.


Notes to Editors:



Advanced Medical Solutions is a UK based company developing and providing
leading edge technology to the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, the Company is focused on the design,
development, manufacture and sale of advanced woundcare dressings and products
for closing wounds and sealing tissue.

AMS provides a full range of advanced woundcare products for sale in hospital,
nursing home and community care markets. The main indications are for chronic
wounds such as ulcers and pressure sores. These products pioneer the concept of
moist wound healing to allow wounds to heal faster and with less pain and
scarring if they remain moist. They protect the wound, deal with tissue fluids
and provide an optimal environment for healing to occur.  AMS' resources ensure
a unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move a product from design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products based upon
cyanoacrylate adhesive technology which allow the closure of wounds following
trauma or surgical incisions, or seal skin to protect against breakdown or wound
infection. These products address the emerging tissue adhesives and sealants
segment of the wound closure market.

AMS' technology and products currently serve the majority of the key global
markets and strategic partners.






                      This information is provided by RNS
            The company news service from the London Stock Exchange